Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn:population based cohort study from the five Nordic countries

To assess whether maternal use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of persistent pulmonary hypertension in the newborn, and whether such an effect might differ between specific SSRIs.

Bibliographic Details
Main Authors:	Kieler, Helle, Artama, Miia, Engeland, Anders, Ericsson, Orjan, Furu, Kari, Gissler, Mika, Beck Nielsen, Rikke, Nørgaard, Mette, Stephansson, Olof, Valdimarsdottir, Unnur, Zoega, Helga, Haglund, Bengt
Format:	Article in Journal/Newspaper
Language:	English
Published:	2012
Subjects:	Adult Depressive Disorder Female Fetus Finland Follow-Up Studies Humans Hypertension Pulmonary Iceland Incidence Infant Newborn Middle Aged Population Surveillance Pregnancy Pregnancy Complications Prospective Studies Risk Factors Scandinavia Serotonin Uptake Inhibitors Young Adult
Online Access:	https://pure.au.dk/portal/da/publications/selective-serotonin-reuptake-inhibitors-during-pregnancy-and-risk-of-persistent-pulmonary-hypertension-in-the-newborn(6cb61690-4b15-4b26-8678-bcd3d9d1ea72).html

Description
Summary:	To assess whether maternal use of selective serotonin reuptake inhibitors (SSRIs) increases the risk of persistent pulmonary hypertension in the newborn, and whether such an effect might differ between specific SSRIs.